Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2007. Start Trial.
Date Value
September 30, 2026 66.02%
August 31, 2026 66.02%
July 31, 2026 66.02%
June 30, 2026 66.02%
May 31, 2026 66.02%
April 30, 2026 66.02%
March 31, 2026 66.02%
February 28, 2026 66.02%
January 31, 2026 66.02%
December 31, 2025 66.02%
November 30, 2025 66.02%
October 31, 2025 66.02%
September 30, 2025 66.02%
August 31, 2025 66.02%
July 31, 2025 66.02%
June 30, 2025 66.02%
May 31, 2025 66.02%
April 30, 2025 66.02%
March 31, 2025 66.02%
February 28, 2025 66.02%
January 31, 2025 66.02%
December 31, 2024 66.02%
November 30, 2024 66.02%
October 31, 2024 66.02%
September 30, 2024 66.02%
Date Value
August 31, 2024 66.02%
July 31, 2024 66.02%
June 30, 2024 66.02%
May 31, 2024 66.02%
April 30, 2024 66.02%
March 31, 2024 66.02%
February 29, 2024 66.02%
January 31, 2024 66.02%
December 31, 2023 66.02%
November 30, 2023 66.02%
October 31, 2023 66.02%
September 30, 2023 66.02%
August 31, 2023 66.02%
July 31, 2023 66.02%
June 30, 2023 52.89%
May 31, 2023 52.89%
April 30, 2023 52.89%
March 31, 2023 45.31%
February 28, 2023 45.31%
January 31, 2023 45.31%
December 31, 2022 45.31%
November 30, 2022 45.31%
October 31, 2022 36.60%
September 30, 2022 36.60%
August 31, 2022 29.20%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Novo Nordisk A/S 74.70%
H. Lundbeck A/S --
AstraZeneca PLC 27.87%
ANI Pharmaceuticals, Inc. 72.96%
Corcept Therapeutics, Inc. 71.85%